Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Prometheus Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 49 | 51 | +2 |
| Shares | 24.2M | 24.3M | +120.0K (+0.5%) |
| Value | $585.6M | $573.2M | −$12.4M (−2.1%) |
New holders (6)
Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 169,734 | $4.02M | 0.00% |
| Ergoteles LLC | 8,791 | $208.0K | 0.01% |
| SG Americas Securities, LLC | 6,396 | $152.0K | 0.00% |
| MetLife Investment Management | 4,911 | $116.4K | 0.00% |
| Metropolitan Life Insurance Co | 3,715 | $88.1K | 0.00% |
| UBS Group AG | 873 | $21.0K | 0.00% |
Sold out (4)
Institutions that held Prometheus Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 38,438 | $944.0K |
| Jump Financial, LLC | 10,311 | $253.0K |
| Kingdon Capital Management, L.L.C. | 8,317 | $204.0K |
| Panagora Asset Management Inc | 245 | $6.00K |